<< back

• Jan Nico Bouwes Bavinck

1. Bouwes Bavinck JN, Vermeer BJ, Gevers Leuven JA, Koopman BJ, Wolthers BG. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis. Arch Dermatol 1986; 122:1269-1272.
2. Bouwes Bavinck JN, Weaver DD. Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Möbius anomalies. Am J Med Genet 1986; 23:903-918.
3. Bouwes Bavinck JN, van Haeringen A, Ruiter D, van der Schroeff JG. Autosomal dominant epidermolysis bullosa dystrophica: are the Cockayne-Touraine, the Pasini and the Bart-types different expressions of the same mutant gene? Clinic Genet 1987; 31:416-424.
4. Bouwes Bavinck JN, Weaver DD, Ellis FD, Ward RE. Brief clinical report: A syndrome of microcephaly, eye anomalies, short stature, and mental deficiency. Am J Med Genet 1987; 26:825-831.
5. Bouwes Bavinck JN, Vermeer BJ, Kootte AMM. Door ultraviolette straling geïnduceerde tumoren bij niertransplantatiepatiënten. In: Vermeer, B. J., van der Schroeff, J. G., and Schothorst, A. A. Photodermatologie. Leiden: Boerhaave Commissie voor Postacademisch Onderwijs in de Geneeskunde, 1988: 65-76.
6. Boom BW, Brand A, Bouwes Bavinck JN, Eernisse JG, Daha MR, Vermeer BJ. Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulin intravenously. Arch Dermatol 1988; 124:1550-1553.
7. Bouwes Bavinck JN, Kootte AMM. Kaposi's sarcoma in a renal transplant recipient. Br J Dermatol 1989; 121:805-806.
8. Mommaas AM, van Praag MCG, Bouwes Bavinck JN, Out-Luiting C, Vermeer BJ, Claas FHJ. Analysis of the protective effect of topical sunscreens on the UVB-radiation-induced suppression of the mixed-lymphocyte-reaction. J Invest Dermatol 1990; 95:313-316.
9. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Claas FHJ. Skin cancer after renal transplantation. In: Claas, F. H. J., Gooszen, H. G., and van der Woude, F. J. New developments in solid organ transplantation. Leiden: Boerhaave Committee for Postgraduate Medical Education, 1990: 239-248.
10. Bouwes Bavinck JN, Kootte AMM, van der Woude FJ, Vandenbroucke JP, Vermeer BJ, Claas FHJ. HLA-A11-associated resistance to skin cancer in renal-transplant recipients. N Engl J Med 1990; 323:1350.
11. van Praag MCG, Boom BW, Schothorst AA, Bouwes Bavinck JN, Kenter CCA, Vermeer BJ. Diagnostiek en behandeling van chronische polymorfe lichtdermatosen. Ned Tijdschr geneeskd 1990; 134:1489-1492.
12. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506-509.
13. Bouwes Bavinck JN, van der Woude FJ, Vandenbroucke JP, Wolterbeek R, Meyboom RH, Vermeer BJ. Cyclosporine for treatment of psoriasis. N Engl J Med 1991; 324:1894 (letter).
14. Bouwes Bavinck JN, Kootte AMM, van der Woude FJ, Vandenbroucke JP, Vermeer BJ, Claas FHJ. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol 1991; 97:269-272.
15. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GMTh, Thorogood J, Persijn GG, Claas FHJ. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325:843-848.
16. van Voorst Vader PC, Bouwes Bavinck JN, Stoltz E, ter Schegget J. Humaan papillomavirus infecties en kanker. Ned Tijdschr Derm Venereol 1991; 1:154-157.
17. Jochmus-Kudielka I, Bouwes Bavinck JN, Gissmann L. Detection of antibodies to the E4 or E7 proteins of human papillomavirus (HPV) in human sera by Western blot analysis: Type-specific reaction of anti-HPV 16 antibodies. Moll Cell Probes 1992; 6:319-325.
18. Bouwes Bavinck JN, Claas FHJ. Immunogenetic and immunological factors associated with the incidence of skin cancer in renal transplant recipients. In: Touraine, J. L. Transplantation and clinical immunology XXIV. Elsevier Science Publishers B.V., 1992: 265-268.
19. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Claas FHJ. HLA-A11 in renal allograft recipients with skin cancer. J Invest Dermatol 1992; 98:262 (reply).
20. Bouwes Bavinck JN, Wolterbeek R, Korstanje MJ, Vermeer BJ. Kans op huidkanker bij de behandeling van psoriasis met ciclosporine. Ned Tijdschr Derm Venereol 1992; 2:171-173.
21. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Claas FHJ. Skin cancer and HLA antigens. N Engl J Med 1992; 326:766.
22. Gruis NA, Bouwes Bavinck JN, Steijlen PM, van der Schroeff JG, van Haeringen A, Happle R, Mariman E, van Beersum SEC, Uitto J, Vermeer BJ, Frants RR. Genetic linkage between collagen VII (COL7A1) gene and the autosomal dominant form of dystrophic epidermolysis bullosa in two Dutch kindreds. J Invest Dermatol 1992; 99:528-530.
23. Jochmus-Kudielka I, Bouwes Bavinck JN, Claas FHJ, Schneider A, van der Woude FJ, Gissmann L. Seroreactivity against HPV 16 E4 and E7 proteins in renal transplant recipients and pregnant women. J Invest Dermatol 1992; 98:389-390.
24. Jonkman MF, Bouwes Bavinck JN. Vooruitgang in onderzoek naar epidermolysis bullosa. Ned Tijdschr Derm Venereol 1993; 3:312-314.
25. Bouwes Bavinck JN, Jonkman MF. Klinische aspecten van epidermolysis bullosa. Ned Tijdschr Derm Venereol 1993; 3:309-311.
26. Bouwes Bavinck JN, de Boer A, Vermeer BJ, Hartevelt MM, van der Woude FJ, Claas FHJ, Wolterbeek R, Vandenbroucke JP. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129:242-249.
27. Bouwes Bavinck JN, Gissmann L, Claas FHJ, van der Woude FJ, Persijn GG, ter Schegget J, Vermeer BJ, Jochmus I, Müller M, Steger G, Gebert S, Pfister H. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 1993; 151:1579-1586.
28. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJM, Vermeer BJ, Jebbink MF, Smits HL. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42:265-280.
29. van Praag MHC, Bouwes Bavinck JN, Bergman W, Rosendaal FR, Mommaas AM, Bruynzeel I, Scheffer E, Vermeer BJ, Bruijn JA. PUVA keratosis; a clinical and histopathological entity associated with an increased risk of non-melanoma skin cancer. J Am Acad Dermatol 1993; 28:412-417.
30. Bouwes Bavinck JN, Marugg ME, Beckers RCY, Vandenbroucke JP, Claas FHJ, Vermeer BJ. The risk of skin cancer among European migrants on Saba. Br J Dermatol 1994; 131:909 (abstract).
31. Bouwes Bavinck JN, Vermeer BJ, Claas FHJ, ter Schegget J, van der Woude FJ. Skin cancer and renal transplantation. J Nephrology 1994; 7:261-267.
32. Bouwes Bavinck JN, Claas FHJ. The role of HLA molecules in the development of skin cancer. Human Immunol 1994; 41:173-179.
33. Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Bruijn JA, van der Woude FJ, ter Schegget J. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994; 131:226-230.
34. van Zuuren EJ, Posma AN, Scholtens REM, Vermeer BJ, van der Woude FJ, Bouwes Bavinck JN. Resurfacing of the hand as treatment and prevention of multiple skin cancers in renal transplant recipients. J Am Acad Dermatol 1994; 31:760-764.
35. D'Amaro J, Houbiers JGA, Drijfhout JW, Brandt RMP, Schipper R, Bouwes Bavinck JN, Melief CJM, Kast WM. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Human Immunol 1995; 43:13-18.
36. Bouwes Bavinck JN, Tieben LM, van der Woude FJ, Tegzess AM, Hermans J, ter Schegget J, Vermeer BJ. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal-transplant recipients; a double-blind, placebo-controlled study. J Clin Oncol 1995; 13:1933-1938.
37. Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33:690-695.
38. Vermeer, BJ, Bouwes Bavinck JN, Claas FHJ. Hautkrebs, HLA-Antigene und HPV. In: Tebbe, B., Goerdt, S., and Orfanos, C. E. Dermatologie, Heutiger Stand. Stuttgart: Georg Thieme Verlag, 1995: 212-215.
39. de Jong-Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105:367-371.
40. Bouwes Bavinck JN, Vermeer BJ. Skin cancer in transplant recipients. Lancet 1995; 346:965 (letter).
41. Bouwes Bavinck JN. Epidemiological aspects of immunosuppression: role of exposure to sunlight and human papillomavirus on the development of skin cancer. Human Exp Toxicol 1995; 14:98.
42. Bouwes Bavinck JN, Robertson I, Wainwright RW, Green A. Excessive skin cancers and pre-malignant skin lesions in an Australian heart-transplant recipient. Brit Heart J 1995; 74:468-470.
43. Müller M, Viscidi RP, Ulken V, Bouwes Bavinck JN, Hill PM, Fisher SG, Reid R, Munoz N, Schneider A, Shah KV, Gissmann L. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. J Invest Dermatol 1995; 104:138-141.
44. van der Pijl JW, Bouwes Bavinck JN, de Fijter JW. Isotretinoin and azathioprine: a synergy that makes hair curl? Lancet 1996; 348:622-623.
45. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, Macnaught A, O'Sullivan B, Siskind V, van der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715-721.
46. Bouwes Bavinck JN, Crijns M, Vermeer BJ, van der Woude FJ, Claas FHJ, Pfister H, Green A, Bergman W. Chronic sun exposure and age are inversely associated with nevi in adult renal transplant recipients. J Invest Dermatol 1996; 106:1036-1041.
47. McGregor JM, Berkhout RJM, Rozycka M, ter Schegget J, Bouwes Bavinck JN, Brooks L, Crook T. P53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997; 15:1737-1740.
48. Boxman ILA, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108:712-715.
49. de Visscher JGAM, Bouwes Bavinck JN, van der Waal I. Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases. Int J Oral Maxillofac Surg 1997; 26:120-123.
50. Hulshof MM, Vandenbroucke JP, Nohlmans LMKE, Spanjaard L, Bouwes Bavinck JN, Dijkmans BAC. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol 1997; 133:33-37.
51. Bouwes Bavinck JN, Berkhout RJM. HPV infections and immunosuppression. Clinics Dermatol 1997; 15:427-437.
52. Bouwes Bavinck JN, Claas FHJ, Hardie DR, Green A, Vermeer BJ, Hardie IR. Relation between skin cancer and HLA antigens in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108:708-711.
53. Stark S, Petridis AK, Ghim S, Jenson BA, Bouwes Bavinck JN, Gross G, Stockfleth E, Fuchs PG, Pfister H. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998; 111:696-701.
54. Vermeer BJ, Bouwes Bavinck JN. Relevance of photo-immunosuppression for viral infections (i.e. human papillomavirus). Eur J Dermatol 1998; 8:205-206.
55. Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors. J Invest Dermatol 1998; 110:880-884.
56. Snels DGCTM, Bouwes Bavinck JN, Muller H, Vermeer BJ. A female patient with the Rothmund-Thomson syndrome associated with anhidrosis and severe infections of the respiratory tract. Dermatology 1998; 196:260-263.
57. Bouwes Bavinck JN, van Zuuren EJ, ter Schegget J. Cutaneous warts and carcinomas. In: Euvrard, S., Kanitakis, J., and Claudy, A. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 122-130.
58. van Zuuren EJ, de Visscher JGAM, Bouwes Bavinck JN. Carcinoma of the lip in kidney transplant recipients. J Am Acad Dermatol 1998; 38:497-499.
59. Vermeer, BJ, Bouwes Bavinck JN. Retinoids for the treatment of the process of carcinogenesis in photoaged skin. In: Dyall-Smith, D. and Marks, R. Dermatology at the millennium. The proceedings of the 19th World Congress of Dermatology Sydney, Australia, 15-20 June, 1997. New York, London: The Parthenon Publishing Group, 1999: 502-504.
60. Vermeer, BJ, Bouwes Bavinck JN, Bruijn JA. Sarcomas of the skin. In: Chu, A. C. and Edelson, R. L. Malignant tumors of the skin. London, Sydney, Auckland: Arnold, 1999: 198-226.
61. Boxman ILA, Mulder LHC, Russell A, Bouwes Bavinck JN, Green A, ter Schegget J. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 1999; 141:246-249.
62. Boxman ILA, Hogewoning A, Mulder LHC, Bouwes Bavinck JN, ter Schegget J. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J Clin Microbiol 1999; 37:2270-2273.
63. Bastiaens MT, Gruis NA, ter Huurne J, Bouwes Bavinck JN. Variants of melanocortin 1 receptor (MC1R) gene and non-melanoma skin cancer. J Invest Dermatol 1999; 113:500 (abstract).
64. Bastiaens MT, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN. Ephelides are more related to pigmentary constitutional host factors than solar lentigines. Pigment Cell Res 1999; 12:316-322.
65. Bouwes Bavinck JN, Lavrijsen APM. Middelen tegen huidziekten. In: Wesseling, H., Neef, C., de Graeff, P. A., Dupont, A. G., Henning, R. H., Lefebvre, R., Lekkerkerker, J. F. F., Seegers, A. J. M., and Zaagsma, J. Algemene Farmacotherapie. Houten/Diegem: Bohn Stafleu Van Loghum, 1999: 751-771.
66. Williams, H, Naldi L, Diepgen T, Elsner P, Grob JJ, Coenraads PJ, Svensson Å, Bouwes Bavinck JN. Epidemiology of skin disease in Europe. In: Fritsch, P. White book, dermatology in Europe. Innsbruck: European Dermatology Forum, 2000: 5-15.
67. Kuijken I, Bouwes Bavinck JN. Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanism. Biodrugs 2000; 14:319-329.
68. Berkhout RJM, Bouwes Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre) malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38:2087-2096.
69. Boxman ILA, Russell A, Mulder LHC, Bouwes Bavinck JN, ter Schegget J, Green A. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eybrow hairs. Int J Cancer 2000; 86:118-121.
70. Boxman ILA, Mulder LHC, Vermeer BJ, Bouwes Bavinck JN, ter Schegget J, Ponec M. HPV DNA is not detectable in outgrowing cells from explant cultures of skin lesions established at the air-liquid-interface. J Med Virol 2000; 61:281-288.
71. de Jong-Tieben LM, Berkhout RJM, ter Schegget J, Vermeer BJ, de Fijter JW, Bruijn JA, Westendorp RGJ, Bouwes Bavinck JN. The prevalence of human papillomavirus DNA (EV-HPV) in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69:44-49.
72. Hulshof MM, Bouwes Bavinck JN, Bergman W, Masclee AAM, Heickendorff L, Breedveld FC, Dijkmans BAC. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000; 43:1017-1023.
73. Bouwes Bavinck JN, Bastiaens MT, Marugg ME, Beckers RCY, Westendorp RGJ, Vermeer BJ, Claas FHJ. Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba. Arch Dermatol 2000; 136:1019-1022.
74. Bouwes Bavinck JN. Biologic treatment of basal cell carcinoma. Arch Dermatol 2000; 136:774-775.
75. Bouwes Bavinck JN, Stark S, Petridis AK, Marugg ME, ter Schegget J, Westendorp RGJ, Fuchs PG, Vermeer BJ, Pfister H. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000; 142:103-109.
76. van Zuuren EJ, Bastiaens MT, Bouwes Bavinck JN. Basal cell carcinoma on the dorsum of the hand: report of eleven cases. J Eur Acad Dermatol Venereol 2000; 14:307-310.
77. Hogewoning AA, Goettsch W, van Loveren H, de Fijter JW, Vermeer BJ, Bouwes Bavinck JN. Skin infections in renal transplant recipients. Clin Transplantation 2001; 15:32-38.
78. Boxman ILA, Russell A, Mulder LHC, Bouwes Bavinck JN, ter Schegget J, Green A. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 2001; 117:1108-1112.
79. Bouwes Bavinck JN, Feltkamp M, Struijk L, de Fijter JW, ter Schegget J. Wratten en huidkanker bij orgaan getransplanteerden: over de rol van humaan papillomavirusinfectie bij het ontstaan van huidmaligniteiten. Ned Tijdschr Dermatol Venereol 2001; 11:254-257.
80. Bastiaens MT, ter Huurne J, Gruis NA, Bergman W, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 2001; 10:1701-1708.
81. Bastiaens MT, Struijk L, Tjong-A-Hung SP, Gruis N, ter Huurne J, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN, ter Schegget J. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? Mol Carcinog 2001; 30:56-61.
82. Bastiaens MT, ter Huurne J, Kielich C, Gruis N, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN. Melanocortin-1 receptor gene variants determine the risk of non-melanoma skin cancer independent of fair skin type and red hair. Am J Human Genet 2001; 68:884-894.
83. Sidoroff A, Halevy S, Bouwes Bavinck JN, Vailland L, Roujeau JC. Acute generalized exantematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001; 28:113-119.
84. De Hertog SAE, Wensveen CAH, Bastiaens MT, Kielich CJ, Berkhout M, Westendorp RGJ, Vermeer BJ, Bouwes Bavinck JN. The relation between smoking and skin cancer. J Clin Oncol 2001; 19:231-238.
85. Fagot JP, Mockenhaupt M, Bouwes Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis: preliminary results of a case-control study. AIDS 2001; 15:1843-1848.
86. Bouwes Bavinck JN, Wensveen CAM, Fagot JP, Mockenhaupt M, Naldi L, Flahault A, Roujeau JC. Het gebruik van nevirapine en de kans op Stevens-Johnson-syndroom en toxische epdermale necrolyse. Ned Tijdschr Dermatol Venereol 2001; 11:25.
87. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Invest Dermatol Symp Proceed 2001; 6:207-211.
88. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens MT, Bergman W, Willemze R, Bouwes Bavinck JN. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous malignant melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117:294-300.
89. Kennedy C, Naipal A, Gruis NA, Struijk L, ter Schegget J, Willemze R, Claas FHJ, Bouwes Bavinck JN, Doxiadis IIN. MICA gene polymorphism is not associated with an increased risk for skin cancer. J Invest Dermatol 2002; 118:686-691.
90. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J, de Gruijl FR, Gruis NA, Bastiaens MT. Epidemiologie van spinocellulaire carcinomen. Ned Tijdschr Derm Venereol 2002; 12:323-324.
91. Bastiaens MT, Gruis NA, de Gruijl FR, Bouwes Bavinck JN. Epidemiologie van basocellulaire carcinomen. Ned Tijdschr Derm Venereol 2002; 12:325-326.
92. Termorshuizen F, Hogewoning AA, Bouwes Bavinck JN, Goetsch WG, de Fijter JW, van Loveren H. Skin infections in renal transplant recipients and the relation with solar ultraviolet radiation. Clin Transplant 2003; 17:522-527.
93. Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149:363-369.
94. Kennedy C, Bajdik CD, Willemze R, de Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003; 120:1087-1093.
95. Kennedy C, Bastiaens MT, Bajdik CD, Willemze R, Westendorp RGJ, Bouwes Bavinck JN. Effect of smoking and sun on the aging skin. J Invest Dermatol 2003; 120:548-554.
96. Naldi L, Svensson Å, Diepgen T, Elsner P, Grob JJ, Coenraads PJ, Bouwes Bavinck JN, Williams HC. Randomized clinical trials for psoriasis '1977-2000', the EDEN survey. J Invest Dermatol 2003; 120:738-741.
97. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, Westendorp RGW, ter Schegget J, Spaan WJM, Bouwes Bavinck JN. Seroreactivity to Epidermodysplasia Verruciformis-related Human Papillomavirus Types Is Associated with Nonmelanoma Skin Cancer. Cancer Res 2003; 63:2695-2700
98. Rabelink NM, Brakman M, Maartense E, Bril H, Bearda Bakker-Wensveen CAH, Bouwes Bavinck JN. Erythema multiforme versus Stevens-Johnson-syndroom en toxische epidermale necrolyse; belangrijk diagnostisch onderscheid. Ned Tijdschr Geneeskd 2003; 147:2089-2094
99. Struijk L, Bouwes Bavinck JN, Wanningen P, van der Meijden E, Westendorp RG, ter Schegget J, Feltkamp MCW. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003; 121:1531-1535
100. Bouwes Bavinck JN, Feltkamp MC. Milk of human kindness?--HAMLET, human papillomavirus, and warts. N Engl J Med 2004; 350:2639-2642 (Perspective)
101. Bouwes Bavinck JN, Feltkamp MC. Treatment of warts. N Engl J Med 2004; 351:1692-1693 (Reply)
102. van Zuuren EJ, Bouwes Bavinck JN. Evidence-based dermatology. Arch Dermatol 2004; 140:370.
103. Termorshuizen F, Feltkamp MCW, Struijk L, de Gruijl FR, Bouwes Bavinck JN, van Loveren H. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 2004; 122:1456-1462
104. de Graaf YGL, Euvrard S, Bouwes Bavinck JN. Systemic and topical retionoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004; 30:656-661
105. Bastiaens M, Hoefnagel J, Westendorp R, Vermeer BJ, Bouwes Bavinck JN. Solar lentigines are strongly related to sun exposure in contrast to ephilides. Pigment Cell Res 2004; 17:225-229
106. van Coevorden AM, Coenraads PJ, Svensson A, Bouwes Bavinck JN, Diepgen TL, Naldi L, Elsner P, Williams HC. Overview of studies of treatments for hand eczema - the EDEN hand eczema survey. Br J Dermatol 2004; 151:446-451
107. Kennedy C, Bajdik CD, Willemze R, Bouwes Bavinck JN. Chemical exposure other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin. Br J Dermatol 2005; 152:194-197
108. Graaf YG, Schiefer D, Redeker A, Vermeer BJ, Bouwes Bavinck JN, Willemze R, Gruijl FR, Burg SH. p53-Specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals. J Dermatol Sci 2005; 38:228-230
109. de Graaf YG, de Fijter JW, Posma AN, Feltkamp MC, Claas FH, Bouwes Bavinck JN. Skin cancer and other skin disorders in patients following solid organ transplantation. Ned Tijdschr Geneeskd 2005; 149:511-517
110. Struijk L, ter Schegget J, Bouwes Bavinck JN, Feltkamp MC. Human papillomavirus in the aetiology of skin cancer. Ned Tijdschr Geneeskd 2005; 149:518-522
111. de Graaf YG, Basdew VR, Zwan-Kralt N, Willemze R, Bouwes Bavinck JN. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation. Br J Dermatol 2006; 154:493-497
112. Hogewoning AA, Duijvestein M, Boakye D, Amoah AS, Obeng BB, van der Raaij-Helmer EM, Staats CC, Bouwes Bavinck JN, Yazdanbakhsh M, Lavrijsen AP. Prevalence of symptomatic tinea capitis and associated causative organisms in the Greater Accra Region, Ghana. Br J Dermatol 2006; 154:784-786
113. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bouwes Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98:389-395
114. Langan SM, Bouwes Bavinck JN, Coenraads PJ, Diepgen T, Elsner P, Grob JJ, Linder D, Naldi L, Svensson A, Williams HC. Update on the activities of the European Dermato-Epidemiology Network (EDEN). Dermatology 2006; 213:1-2
115. Struijk L, Hall L, van der ME, Wanningen P, Bouwes Bavinck JN, Neale R, Green AC, ter Schegget J, Feltkamp MC. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15:529-535
116. de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006; 126:569-574
117. Williams H, Svensson A, Diepgen T, Naldi L, Coenraads PJ, Elsner P, Grob JJ, Bouwes Bavinck JN. Epidemiology of skin diseases in Europe. Eur J Dermatol 2006; 16:212-218
118. de Graaf YGL, Basdew VR, van der Zwan-Kralt N, Willemze R, Bouwes Bavinck JN. Curettage en coagulatie van plaveiselcelcarcinomen in orgaantransplantatie patienten: resultaten van een open studie. Ned Tijdschr Dermatol Venereol 2006; 16:402-406
119. Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006; 20:834-839
120. 120. Plasmeijer EI, Bouwes Bavinck JN, Feltkamp MCW. Plaveiselcelcarcinomen en humaan papillomavirus infecties. Ned Tijdschr Dermatol Venereol 2006; 16:389-393
121. Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R, Abeni D, Tessari GP, Feltkamp MC, Claudy A, Stockfleth E, Harwood CA. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127:1647-1656
122. de Koning MN, Struijk L, Bouwes Bavinck JN, Kleter B, ter Schegget J, Quint WG, Feltkamp MC. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88:1489-1495
123. Sidoroff A, Dunant A, Viboud C, Halevy S, Bouwes Bavinck JN, Naldi L, Mockenhaupt M, Fagot JP, Roujeau JC. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007; 157:989-996
124. Bouwes Bavinck JN, de Fijter JW. Systemic retinoids for prevention of skin cancer in organ transplant recipients. In: Otley CC and Stasko T. Skin disease in organ transplantation. Cambridge: Cambridge University Press, 2008: 272-276.
125. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC. Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008; 128:1355-1358
126. de Graaf YG, Rebel H, Elghalbzouri A, Cramers P, Nellen RG, Willemze R, Bouwes Bavinck JN, de Gruijl FR. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine. Exp Dermatol 2008; 17:349-355
127. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58:25-32
128. Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18:99-107
129. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128:35-44
130. Matin RN, Mesher D, Proby CM, McGregor JM, Bouwes Bavinck JN, Del M, V, Euvrard S, Ferrandiz C, Geusau A, Hackethal M, Ho WL, Hofbauer GF, Imko-Walczuk B, Kanitakis J, Lally A, Lear JT, Lebbe C, Murphy GM, Piaserico S, Seckin D et al. Melanoma in Organ Transplant Recipients: Clinicopathological Features and Outcome in 100 Cases. Am J Transplant 2008; 8:1891-1900
131. Van der Linde AA, Pillen S, Gerrits GP, Bouwes Bavinck JN. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Clin Toxicol (Phila) 2008; 46:479-481